Navigation Links
Brain Tumor Patients Survival Depends on Predicting Treatment Responses Earlier

WASHINGTON, D.C. A first-of-its-kind study presented at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals , declares that use of metabolic or molecular imaging to measure brain tumor patients' response to treatment is a powerful predictor of survival.

"Our study opens the door to the possibility that brain tumor patients may live longer and respond better to drug treatments," said Wei Chen, assistant professor in the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine, University of California, Los Angeles. "Malignant brain tumors are very difficult to treat. Typically, patients live for three months without treatment and up to a year with treatment," she said.

Using positron emission tomography (PET) imagingwith the radiotracer FLT (fluorothymidine)UCLA researchers were able to determine within one or two weeks after starting the treatment whether patients were responding well to the drugs bevacizumab and irinotecan. This quick response determination "is unheard of" with the traditionally used magnetic resonance imaging, a procedure that looks at the anatomy rather than metabolic activities of tumor cells, she explained. With MRI, it is often difficult to tell tumor growth from changes caused by treatment (such as radiation). In addition, it could take months before it's known whether a patient is responding to treatment, said Chen.

A brain tumor is an abnormal mass of tissue that grows and multiplies uncontrollablytaking up space within the skull and interfering with the brain's vital functions. Malignant brain tumors are rapidly fatal, said Chen. This year, nearly 21,000 people in this country will be diagnosed with brain and other related nervous system tumors in this country and nearly 13,000 individuals will die from them. Neurooncologists are desperately in need of an imaging modality that could evaluate reliably and
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
(Date:12/5/2008)...yzoom provides physicians and their office manager... Columbus, OH (PRWEB) Decemb...as launched Phase I of PHYZOOM, a suite of web-bas...icians, PHYZOOM offers numerous practice marketing...sician and practice profiles, easy to use blogging...
(Date:12/4/2008)...swire-USNewswire/ -- In the 1983 movie "A Christma...hat a Red Ryder BB gun is the perfect gift. , ... he got from his parents, teacher and even Santa C... quotes from this Christmas classic because we,ve ...unfortunately, it comes true for too many people. ...
(Date:12/4/2008)... people over a 20-year period suggests your smile ..., Dec. 4 (HealthDay News) -- Happy friends can mak...iends. , That,s the unusual conclusion of a new...et can have an impact on each other,s feelings. ,...le we,re directly connected to," said study co-aut...
(Date:12/4/2008)...re-USNewswire/ -- The U.S. Government, through the..., is providing an additional $600,000 to help comb...nce is in addition to the $4 million water, sanita...dy implementing in Zimbabwe. , , "Before ch...the international community to prepare for the pos...
Breaking Medicine News(10 mins):Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 3Health News:Texas Parents Can Prevent Holiday Tragedies with Safe Toys and Celebrations 2Health News:Being Happy Affects Even Those You Don't Know 2Health News:Being Happy Affects Even Those You Don't Know 3Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2
...rd researchers suggests a link between the hepatit...study, people who received the vaccine were three-...hree years than those who were not vaccinated. Whi...tigators emphasize the overall effect of the vacci...
... an increased risk for life-threatening cardiovasc...etes would be well // advised to monitor their blo..., according to a new study. Researchers conducted ...ed observational studies focused on the relationsh...
...itis in asthma patients tends to be more severe an...hers suggest patients // can have dramatic improve...surgical options is used. In the study patients wi...cidence of nasal polyps, olfactory dysfunction, an...
... designed to educate parents about allergens and t...in children // say researchers .More than 900 ch... allergic to at least one indoor environmental all...earch shows children who live in these areas suffe...
Other Medicine News:
(Date:12/3/2008)..., Dec. 3 Isogen, a contract develo...filling, announced it has retained a,strategic fi...et the global,biopharma demand for Isogen,s servi...ccessful first round series of capital,investment...y in Q1 2009 to,deliver on the previously unmet p...
(Date:12/3/2008)...Calif., Dec. 3 Bionovo, ...DA has reviewed the company,s,manufacturing and c...d,guidance on how Bionovo can move forward with t...for menopausal hot flashes. , "We have conc...moving to,address the Agency,s recommendations fo...
(Date:12/2/2008).... 3 Researchers using f...cuitry in the area of the brain,responsible for s...fering from,stress-related psychiatric disorders....the annual meeting of the Radiological Society of ... major depression and other stress-related disorde...
(Date:12/2/2008)...ass., Dec. 2 Biopure Cor...he U.S. Naval Medical Research Center,(NMRC) has ...) a revised,investigational new drug (IND) applic...s oxygen therapeutic Hemopure(R) [hemoglobin gluta...eld treatment of trauma patients. The study is,en...
Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3BrainCells Inc Completes 2430 Million Initial Closing of Series B Financing 3816 1BrainCells Inc Completes 2430 Million Initial Closing of Series B Financing 3816 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 1Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 3Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 4Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 5Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 1Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 2Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 3Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 4Fralex reaches 100th patient milestone in fibromyalgia study 3810 1Fralex reaches 100th patient milestone in fibromyalgia study 3810 2Fralex reaches 100th patient milestone in fibromyalgia study 3810 3
...pril 2007. Giaconda Ltd (ASX: GIA) today,announced...s,approved the Company,s Investigational New Drug ...MyocondaR to treat patients with,Crohn,s Disease i...sis (MAP). , ,The Company understands that its lea...ubmitted to the FDA for this indication. There,are...
... 160th Annual Meeting of the American,Psychiatric ...-FirstCall/ -- In adults with,major depressive dis...py (ADT) resulted in significant improvement in th...ion Rating Scale (MADRS),Total Score. In this six-...ed here at the 160th Annual Meeting of the America...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material.
Table-mounted, retraction for radiolucent anterior spine procedures. Fully-adjustable for any approach and any patient. Combine with our radiolucent blade kit for optimal visibility.
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation.
Medicine Products: